Can AI and digital pathology help diagnose endometrial cancer better than standard methods?
AI and digital pathology are emerging tools that could help diagnose endometrial cancer more accurately than standard methods alone. Standard diagnosis relies on a pathologist examining tissue under a microscope, which can miss subtle features. AI can analyze digital images of tissue and integrate molecular data to detect patterns that may be invisible to the human eye. While research is promising, these technologies are still being validated and are not yet widely used in routine care.
What the research says
A 2025 narrative review highlights that AI and machine learning are now essential for linking tissue morphology (structure) with molecular changes in endometrial cancer, enabling predictions of treatment response and survival 3. The same review notes that combining image-based and molecular approaches can improve diagnostic accuracy beyond standard pathology 3. Another review on precision prevention mentions that emerging strategies like AI require further validation before they can be used in clinical practice 2. A 2025 study on sentinel lymph node dissection in endometrial cancer found that AI can help assess surgical videos to standardize quality and improve lymph node detection, which is critical for staging 9. While these studies show potential, they also emphasize challenges such as standardization, reproducibility, and regulatory approval that must be addressed before AI can replace or augment standard methods 3.
What to ask your doctor
- Are there any hospitals or labs in our area that use AI or digital pathology for endometrial cancer diagnosis?
- How does AI analysis compare to standard pathology for my specific type of endometrial cancer?
- Is digital pathology covered by my insurance or available as part of a clinical trial?
- What are the limitations of AI in diagnosing endometrial cancer that I should be aware of?
- Could AI help determine my prognosis or guide treatment decisions in the future?
This question is drawn from common patient questions about Oncology and answered using cited medical research. We do not provide individualized advice.